Pay in 4 interest-free payments of $7.49 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
Minimal immunogenic potential: Long-term studies in rodents and primates report no antibody formation, suggesting a low risk of immune reactions following repeated exposure to the peptide
Known as Body Protection Compound with broad research interests Commonly used within studies of recovery and regeneration Interesting for research on muscles, tendons and joints Unique link to the digestive system Suitable for various experimental applications within life sciences The combination of versatility and intense research interest has made BPC-157 a fixture within modern peptide research
Our medical team provides thorough training for self-injection at home, or patients may choose to come in for in-office administration
Across the 4,590 ASCs in the ASCQR Program, the estimated annual burden is between $2,074,680 and $2,420,766
The estimated CY 2025 payments are expressed in millions of dollars
US$ 25.29
US$ 20.12
US$ 27.12
US$ 29.91
US$ 20.16
US$ 21.19
